RecruitingNCT04838171

Prospective Study of White Blood Cells

Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies

Sponsor

Quell Therapeutics Limited

Enrollment

10 participants

Start Date

Mar 24, 2021

Study Type

OBSERVATIONAL

Conditions

Inflammation Autoimmune Diseases Rejection; Transplant, Liver

Summary

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying White blood cell and blood collection for people with autoimmune diseases, inflammation, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.